ALFA FinderNSE filing, NSE: THEMISMED. Summary written from the filing by ALFA Finder's alert engine.
Themis Medicare Ltd: key numbers
- Share price
- ₹101.58
- Market cap
- ₹935.5 Cr
- Revenue (annual)
- ₹342.2 Cr
- Net profit (annual)
- ₹1.14 Cr
- P/E (TTM)
- 23.4×Sector 43.4×
- Promoter holding
- 67.11%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Themis Medicare Ltd
All →Themis Medicare Other Announcement
Themis Medicare has filed a revised September 2026 quarter shareholding pattern. It reclassifies trustees as promoter group and adds OSS Software Solutions as a nil-holding promoter group member.
Themis Medicare Board Meeting Date
Themis Medicare's board is scheduled for November 5, 2026, to approve quarterly and half-year financial results. The trading window remains closed until 48 hours post-results publication.
Themis Medicare Share Pledge
Promoter Vividhmargi pledged 15 lakh Themis Medicare shares for a Rs 135 Crore borrowing. Total encumbrance rises to 4.89% of capital.
- Value
- ₹135.0 Cr
Themis Medicare Management Change
Themis Medicare proposes re-appointing Independent Director Bhaskar Vemban Iyer for a second five-year term from 12 November 2026. Postal ballot notice dispatched to members seeking approval.
Themis Medicare Annual General Meeting
Themis Medicare seeks shareholder approval via postal ballot for a special resolution re-appointing Mr. Bhaskar Iyer as Independent Director for a second five-year term. Remote e-voting runs 24 October to 22 November 2026.
Themis Medicare Other Announcement
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Other price movement clarification announcements
All →Banka Bioloo Price Movement Clarification
Banka BioLoo responded to NSE's query on a significant price movement, stating the spurt was market-driven. The company says it has made all required disclosures and has no pending price-sensitive announcement.
Vaibhav Vyapaar Price Movement Clarification
Vaibhav Vyapaar responded to NSE's surveillance query on a significant share price movement. The company states no undisclosed material event exists and the move appears market-driven.
TVS Electronics Price Movement Clarification
TVS Electronics Limited responded to NSE's query on a significant increase in trading volume, stating it has no pending information to disclose under Regulation 30. The response confirms all price-sensitive information has already been disclosed.
Moving Media Entertainment Price Movement Clarification
Moving Media Entertainment clarified to NSE a significant share price movement, stating it has no unpublished price-sensitive information. The company attributes the movement to market conditions and external factors.
Aerpace Industries Price Movement Clarification
Aerpace Industries clarified that recent significant movement in its share price is market-driven. The company confirmed it has no undisclosed material information impacting the stock price.
Sotac Pharmaceuticals Price Movement Clarification
Sotac Pharmaceuticals clarified that recent share price movements are entirely market-driven. The company confirmed it has disclosed all material information in compliance with SEBI regulations.